Pancreatic Cancer
Updated: 01/25/2006

References

Abiaka CD, Al-Awadi FM et al. Plasma micronutrient antioxidant in cancer patients. Cancer Detect Prev . 2001;25(3):245-53.

Ahn WS, Yoo J et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev . 2003;12(5):383-90.

Alarcon de la Lastra C, Barranco MD et al. Mediterranean diet and health: biological importance of olive oil. Curr Pharm Des . 2001;7(10):933-50.

Alcock RA, Dey S et al. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. Oncogene . 2002;21(51):7883-90.

Alguacil J, Porta M et al. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer. Int J Cancer . 2003;107(4):635-41.

Aller R, de Luis DA et al. Effect of soluble fiber intake in lipid and glucose levels in healthy subjects: a randomized clinical trial. Diabetes Res Clin Pract . 2004;65(1):7-11.

American Cancer Society. Cancer Facts and Figures 2005.2005.

Anderson KM, Seed T et al. NTBN, a free radical spin trap induces programmed cell death in human pancreatic cancer (PANC-1) cells. Anticancer Research . 1998a;18(5A):3213-22.

Anderson KM, Seed T et al. Five-lipoxygenase inhibitors reduce Panc-1 survival: the mode of cell death and synergism of MK886 with gamma linolenic acid. Anticancer Res . 1998b;18(2A):791-800.

Andren-Sandberg A, Johansson J. Influence of sex hormones on pancreatic cancer. Int J Pancreatol . 1990;7(1-3):167-76.

Ansari MS, Gupta NP. Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer. Urol Oncol . 2004;22(5):415-20.

Appel MJ, Woutersen RA. Effects of dietary beta-carotene and selenium on initiation and promotion of pancreatic carcinogenesis in azaserine-treated rats. Carcinogenesis . 1996;17(7):1411-6.

Armstrong T, Walters E et al. Deficiencies of micronutrients, altered bowel function, and quality of life during late follow-up after pancreaticoduodenectomy for malignancy. Pancreatology . 2002;2(6):528-34.

Bai J, Sata N et al. Genistein-induced changes in gene expression in Panc 1 cells at physiological concentrations of genistein. Pancreas . 2004;29(2):93-8.

Bai YR, Wu GH et al. Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: results of feasibility study. World J Gastroenterol . 2003;9(11):2561-4.

Baker CH, Kedar D et al. Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. Am J Pathol . 2002a;161(3):929-38.

Baker CH, Solorzano CC et al. Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res . 2002b;62(7):1996-2003.

Banerjee S, Zhang Y et al. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res . 2005;65(19):9064-72.

Barber MD, Fearon KC. Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia. Lipids 2001;36(4):347-51.

Barber MD, McMillan DC et al. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) . 2000;98(4):389-99.

Barber MD, Ross JA et al. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Brit J Cancer . 1999;81(1):80-6.

Bartsch DK, Sina-Frey M et al. CDKN2A germline mutations in familial pancreatic cancer. Ann Surg . 2002;23(6):730-7.

Bauer JD, Capra S. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy-a pilot study. Support Care Cancer . 2004; IN PRESS.

Belanger JT. Perillyl alcohol: applications in oncology. Altern Med Rev . 1998;3(6):448-57.

Berrington de Gonzalez A, Sweetland S et al. A meta-analysis of obesity and the risk of pancreatic cancer. British Journal of Cancer . 2003;89(3):519-23.

Berrozpe G, Schaeffer J et al. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer . 1994;58(2):185-91.

BioDrugs, 2002. Cancer vaccine--antigenics. BioDrugs 2002;16(1):72-4.

Bjelakovic G, Nikolova D et al. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet . 2004;364(9441):1219-28.

Blumenthal RD, Hansen HJ et al. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (carcinoembryonic antigen). Cancer Res . 2005;65(19):8809-17.

Boadas J, Mora J et al. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer. Eur J Gastroenterol Hepatol . 2001 Oct;13(10):1153-9.

Boari C, Montanari FM et al. [Toxic occupational liver diseases. Therapeutic effects of silymarin]. Minerva Med . 1981;72(40):2679-88.

Boik J. Natural Compounds in Cancer Therapy: Promising Nontoxic Antitumor Agents from Plants and Other Natural Sources . Princeton, MN: Oregon Medical Press; 2001.

Boros LG, Bassilian S et al. Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth. Pancreas . 2001;22(1):1-7.

Bouvet M, Nardin SR et al. Parathyroid hormone-related protein as a novel tumor marker in pancreatic adenocarcinoma. Pancreas . 2002;24(3):284-90.

Braga M, Cristallo M et al. Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function. Surg Gynecol Obstet . 1988;167(6):485-92.

Brand R. The diagnosis of pancreatic cancer. Cancer J . 2001;7(4):287-97.

Brasiuniene B, Brasiunas V et al. Molecular factors of pancreatic cancer pathogenesis and prognosis. Medicina (Kaunas) . 2003;39(7):631-6.

Broitman SA, Wilkinson J et al. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo. Adv Exp Med Biol . 1995;401:111-30.

Bruno MJ, Haverkort EB et al. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am J Gastroenterol . 1995a;90(9):1383-93.

Bruno MJ, Hoek FJ et al. Simultaneous assessments of exocrine pancreatic function by cholesteryl-[14C]octanoate breath test and measurement of plasma p-aminobenzoic acid. Clin Chem . 1995b;41(4):599-604.

Buchler P, Gukovskaya AS et al. Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid. Pancreas . 2003;26(3):264-73.

Buchler P, Reber HA et al. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Cancer . 2004;100(1):201-10.

Burke YD, Ayoubi AS et al. Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. Anticancer Research . 2002;22(6A):3127-34.

Burns, CP, Halabi, S, et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res 1999;5(12):3942-7.

Burris HA3. Objective outcome measures of quality of life. Oncology (Williston Park) . 1996;10(11 Suppl):131-5.

Cai J, Jiang WG et al. Inhibition of angiogenic factor- and tumour-induced angiogenesis by gamma linolenic acid. Prostaglandins Leukot Essent Fatty Acids . 1999;60(1):21-9.

Caldas C, Hahn SA et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res . 1994 Jul 1;54(13):3568-73.

Chen da W, Wei Fei Z et al. Role of enteral immunonutrition in patients with gastric carcinoma undergoing major surgery. Asian J Surg . 2005;28(2):121-4.

Chen X, Yano Y et al. Inhibition of farnesyl protein transferase and P21ras membrane association by d-limonene in human pancreas tumor cells in vitro. Chin Med Sci J . 1999;14(3):138-44.

Choi YH, Lee WH et al. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn J Cancer Res . 2000;91(2):164-73.

Chow HH, Cai Y et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev . 2001;10(1):53-8.

Chow HH, Cai Y et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res . 2003;9(9):3312-9.

Chu J, Lloyd FL et al. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer. Mol Cancer Ther . 2003;2(1):1-7.

Cleary SP, Gryfe R et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg . 2004;198(5):722-31.

Comstock GW, Helzlsouer KJ et al. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr . 1991;53((1 Suppl)):260S-4S.

Corbishley TP, Iqbal MJ et al. Circulating sex steroids and sex hormone binding globulin in pancreatic adenocarcinoma. Anticancer Res . 1986;6(2):219-22.

Coss A, Cantor KP et al. Pancreatic cancer and drinking water and dietary sources of nitrate and nitrite. Am J Epidemiol . 2004;159(7):693-701.

Cowgill SM, Muscarella P. The genetics of pancreatic cancer. Am J Surg . 2003;186(3):279-86.

Crane CH, Mason K et al. Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer. Am J Clin Oncol . 2003;26(4):81-4.

Crowell PL, Siar AA et al. Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer. Adv Exp Med Biol . 1996;401:131-6.

Cuendet M, Pezzuto JM. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Interact . 2000;17(1-4):109-57.

Cullen JJ, Mitros FA et al. Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas . 2003;26(1):23-7.

DeMeo MT. Pancreatic cancer and sugar diabetes. Nutr Rev . 2001;59(4):112-5.

Dimagno EP, Reber HA et al. AGA technical review on the epidemiology, diagnosis and treatment of pancreatic ductal adenocarcinoma. Gastroenterol Clin Biol . 1999;117:1464-84.

Ding XZ, Tong WG et al. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Research . 2000;20(4):2625-31.

Ding XZ, Tong WG et al. Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer. Pancreatology . 2001;1(4):291-9.

El-Metwally TH, Adrian TE. Optimization of treatment conditions for studying the anticancer effects of retinoids using pancreatic adenocarcinoma as a model. Biochemical & Biophysical Research Communications . 1999;257(2):596-603.

Ertekin MV, Koc M et al. The effects of oral zinc sulphate during radiotherapy on anti-oxidant enzyme activities in patients with head and neck cancer: a prospective, randomised, placebo-controlled study. Int J Clin Pract . 2004;58(7):662-8.

Fearon KC, Falconer JS et al. An open-label phase I/II dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate. Anticancer Research . 1996;16(2):867-74.

Ferrari V, Valcamonico F et al. Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial. Cancer Chemother Pharmacol . 2005;1-6.

Ferreira PR, Fleck JF et al. Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial. Head Neck . 2004;26(4):313-21.

Ferry DR, Deakin M et al. A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints. Ann Oncol . 2000;11(9):1165-70.

Fosslien E. Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci . 2000;37(5):431-502.

Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr . 2003;133(10):3275S-84S.

Friess H, Wang L et al. Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. Ann Surg . 1999;230(6):767-74.

Fujioka S, Sclabas GM et al. Function of nuclear factor kappaB in pancreatic cancer metastasis. Clin Cancer Res . 2003;9(1):346-54.

Gail MH, You WC et al. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. Control Clin Trials . 1998;19(4):352-69.

Ganepola GA, Gritsman AY et al. Are pancreatic tumors hormone dependent?: A case report of unusual, rapidly growing pancreatic tumor during pregnancy, its possible relationship to female sex hormones, and review of the literature. Am Surg . 1999;65(2):105-11.

Gansauge F, Ramadani M et al. NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial. Langenbecks Archives of Surgery . 2002;386(8):570-4.

Gapstur SM, Gann PH et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA . 2000;283(19):2552-8.

Garcea G, Dennison AR et al. Role of inflammation in pancreatic carcinogenesis and the implications for future therapy. Pancreatology . 2005;5(6):514-29.

Gelb MH, Tamanoi F et al. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett . 1995;91(2):169-75.

Gescher A. Polyphenolic phytochemicals versus non-steroidal anti-inflammatory drugs: which are better cancer chemopreventive agents? J Chemother . 2004;16 Suppl 4:3-6.

Ghadirian P, Lynch HT et al. Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev . 2003;27(2):87-93.

Gjertsen MK, Buanes T et al. Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma. Int J Cancer . 2001;92(3):441-50.

Gjertsen MK, Saeterdal I et al. HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes. J Mol Med . 2003;81(1):43-50.

Gogos CA, Ginopoulos P et al. Dietary omega-3 fatty polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: A randomized control trial. Cancer . 1998;82(2):395-402.

Gold DV, Cardillo T et al. Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monocloncal antibody PAM4. Int J Cancer . 1997;71(4):660-7.

Gold DV, Lew K et al. Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin. Int J Cancer . 1994;57(2):204-10.

Gold DV, Schutsky K et al. Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer. Clin Cancer Res . 2003;9(10 Pt 2):3929S-39S.

Goldstein D, Carroll S et al. Modern management of pancreatic carcinoma. Intern Med J . 2004;34(8):475-81.

Gonzalez NJ, Isaacs LL. Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support. Nutr Cancer . 1999;33(2):117-24.

Grant AG, McGlashan D et al. A study of pancreatic secretory and intracellular enzymes in pancreatic cancer tissue, other gastrointestinal cancers, normal pancreas and serum. Clin Chim Acta . 1978;90(1):75-82.

Grutzmann R, Pilarsky C et al. Systematic isolation of genes differentially expressed in normal and cancerous tissue of the pancreas. Pancreatology . 2003;3(2):169-78.

Grzesiak JJ, Clopton P et al. The extracellular matrix differentially regulates the expression of PTHrP and the PTH/PTHrP receptor in FG pancreatic cancer cells. Pancreas . 2004;29(2):85-92.

Grzesiak JJ, Smith KC et al. GSK3 and PKB/Akt are associated with integrin-mediated regulation of PTHrP, IL-6 and IL-8 expression in FG pancreatic cancer cells. Int J Cancer . 2005;114(4):522-30.

Guo JM, Xiao BX et al. Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells in vitro. World J Gastroenterol . 2004;10(6):860-3.

Hansel DE, Ashfaq R et al. A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment. Am J Clin Pathol . 2005;123(1):28-35.

Hardcastle IR, Rowlands MG et al. Inhibition of protein prenylation by metabolites of limonene. Biochem Pharmacol . 1999;57(7):801-9.

Heisler T, Towfigh S et al. Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth. Journal of Surgical Research . 2000;88(1):23-5.

Hennig R, Ding XZ et al. 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. American Journal of Pathology . 2002;161(2):421-8.

Hernaandez J, Syed S et al. The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial. J Urol . 2005;174(2):519-22.

Hidaka H, Ishiko T et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer . 2002;95(6):1206-14.

Higashi T, Saga T et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) -- usefulness and limitations in "clinical reality". Ann Nucl Med . 2003;17(4):261-79.

Hiura A, Tsutsumi M et al. Inhibitory effect of green tea extract on the process of pancreatic carcinogenesis induced by N-nitrosobis-(2-oxypropyl)amine (BOP) and on tumor promotion after transplantation of N-nitrosobis-(2-hydroxypropyl)amine (BHP)-induced pancreatic cancer in Syrian hamsters. Pancreas . 1997;15(3):272-7.

Hoos A, Levey DL. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications. Expert Rev Vaccines . 2003;2(3):369-79.

Hoppin JA, Tolbert PE et al. Pancreatic cancer and serum organochlorine levels. Cancer Epidemiol Biomarkers Prev . 2000;9(2):199-205.

Hotz HG, Hines OJ et al. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. Surgery . 2005;137(2):192-9.

Igimi H, Hisatsugu T et al. The use of d-limonene preparation as a dissolving agent of gallstones. Am J Dig Dis . 1976;21(11):926-39.

Irigoyen Oyarzabal AM, Amiguet Garcia JA et al. [Tumoral markers and acute-phase reactants in the diagnosis of pancreatic cancer]. Gastroenterol Hepatol . 2003;26(10):624-9.

Ito K, Nakazato H et al. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up. Int J Colorectal Dis . 2004;19(2):157-64.

Jaffee EM, Abrams R et al. A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. Hum Gene Ther . 1998;9(13):1951-71.

Jaffee EM, Hruban RH et al. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol . 2001;19(1):145-56.

Ji BT, Chow WH et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer . 1997;70(3):255-8.

Jia L, Zhang MH et al. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice. World J Gastroenterol . 2005;11(3):447-50.

Jiang XT THZSC. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer. Hepatobiliary Pancreat Dis Int . 2004;3(3):464-8.

Joshi SS, Kuszynski CA et al. The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. Curr Pharm Biotechnol . 2001;2(2):187-200.

Kairemo KJ, Jekunen AP et al. The effect of lithium gamma-linolenate therapy of pancreatic cancer on perfusion in liver and pancreatic tissues. Pancreas . 1998;16(1):105-6.

Karlson J, Borg-Karlson AK et al. Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of action. Anticancer Drugs . 1996;7(4):422-9.

Katdare M, Osborne MP et al. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals. Oncol Rep . 1998;5(2):311-5.

Kim T. Technology evaluation: Matuzumab, Merck KGaA. Curr Opin Mol Ther . 2004;6(1):96-103.

Kim YI. Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr Rev . 1999;57(10):314-21.

Kim YI, Baik HW et al. Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial. Am J Gastroenterol . 2001;96(1):184-95.

Kise Y, Yamamura M et al. Inhibitory effect of selenium on hamster pancreatic cancer induction by N'-nitrosobis(2-oxopropyl)amine. Int J Cancer . 1990;46(1):95-100.

Klek S, Kulig J et al. The clinical value of parenteral immunonutrition in surgical patients. Acta Chir Belg . 2005;105(2):175-9.

Koda K, Miyazaki M et al. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines. Int J Oncol . 2003;23(1):165-72.

Kokawa A, Kondo H et al. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer . 2001;91(2):333-8.

Konner J, O'Reilly E. Pancreatic cancer: epidemiology, genetics, and approaches to screening. Oncology 2002; 16(12): 1615-22, 1631-2; discussion 1632-3, 1637-8.

Korutla L, Cheung JY et al. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis . 1995;16(8):1741-5.

Kurosaki I, Hatakeyama K. Adjuvant Systemic Chemotherapy with Gemcitabine for Stage IV Pancreatic Cancer: A Preliminary Report of Initial Experience. Chemotherapy 2005;51(6):305-10.

La Vecchia C, Negri E. Fats in seasoning and the relationship to pancreatic cancer. European Journal of Cancer Prevention . 1997;6(4):370-3.

Lai PB, Ross JA et al. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. British Journal of Cancer . 1996;74(9):1375-83.

Lamerz R. Role of tumor markers, cytogenetics. Ann Oncol . 1999;10(Suppl 4):145-9.

Lei S, Appert HE et al. Overexpression of HER2/neu oncogene in pancreatic cancer correlates with shortened survival. Int J Pancreatol . 1995;17(1):15-21.

Levy MJ, Wiersema MJ. Endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. Oncology (Huntingt) . 2002;16(1):29-38.

Li D, Jiao L. Molecular epidemiology of pancreatic cancer. Int J Gastrintest Cancer . 2003;33(1):3-14.

Li L, Aggarwal BB et al. Nuclear factor-kappaB and IkappaBkinase are constitutively active in human pancreatic cells and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer . 2004;101(10):2351-62.

Li Y, Ahmed F et al. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res . 2005;65(15):6934-42.

Li Y, Ellis KL et al. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BXPC-3 pancreatic cancer cell line. Pancreas . 2004;28(4):90-5.

Lian F, Li Y et al. p53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer . 1999;33(2):125-31.

Lian JP, Word B et al. Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein. Anticancer Res . 2004;24(1):133-7.

Liang YC, Lin-shiau SY et al. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem . 1997;67(1):55-65.

Lipton A, Harvey H et al. Gemcitabine/Irinotecan/celecoxib in pancreatic cancer. Oncology (Williston Park) . 2004;18(14 Suppl 14):43-5.

Lowenfels AB, Maisonneuve P. Epidemiologic and etiologic factors of pancreatic cancer. Hematol Oncol Clin North Am . 2002;16(1):1-16.

Lowenfels AB, Maisonneuve P. Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol . 2004;34(5):238-44.

Lu ZX, Walker KZ et al. Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects. Am J Clin Nutr . 2000;71(5):1123-8.

Lyn-Cook BD, Rogers T et al. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer . 1999a;35(1):80-6.

Lyn-Cook BD, Rogers T et al. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer . 1999b;35(1):80-6.

Maiti TK, Chatterjee J et al. Effect of green tea polyphenols on angiogenesis induced by an angiogenin-like protein. Biochem Biophys Res Commun . 2003;308(1):64-7.

Masamune A, Kikuta K et al. Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World J Gastroenterol . 2005;11(22):3368-74.

McBride G. Screening methods may offer early diagnosis of pancreatic cancer. J Natl Cancer Inst 2004;96(21):1571.

McIntyre BS, Sylvester PW. Genistein and erbstatin inhibition of normal mammary epithelial cell proliferation is associated with EGF-receptor down-regulation. Cell Prolif . 1998;31(1):35-46.

McKenna WG, Muschel RJ. Targeting tumor cells by enhancing radiation sensitivity. Genes Chromosomes Cancer . 2003;38(4):330-8.

Merendino N, Molinari R et al. Induction of apoptosis in human pancreatic cancer cells by docosahexaenoic acid. Ann N Y Acad Sci . 2003;1010:361-4.

Michaud DS. Epidemiology of pancreatic cancer. Minerva Chir . 2004;59(2):99-111.

Michaud DS, Liu S et al. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst . 2002;94(17):1293-300.

Milella M, Gelibter A et al. Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma. Cancer . 2004;101(1):133-8.

Miltyk W, Craciunescu CN et al. Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer. Am J Clin Nutr . 2003;77(4):875-82.

Missiaglia E, Donadelli M et al. Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway. Oncogene . 2005;24(1):199-211.

Modrak DE, Cardillo TM et al. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer. Cancer Res . 2004;64(22):8405-10.

Moniaux N, Varshney GC et al. Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans. J Histochem Cytochem . 2004;52(2):253-61.

Moore PS, Beghelli S et al. Genetic abnormalities in pancreatic cancer. Mol Cancer . 2003;2(1):7.

Morgan-Meadows S, Dubey S et al. Phase I trial of perillyl alcohol administered four times daily continuously. Cancer Chemother Pharmacol . 2003;52(5):361-6.

Moses AW, Slater C et al. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer . 2004;90(5):996-1002.

Naderi A, Couch FJ. BRCA2 and pancreatic cancer. Int J Gastrointest Cancer . 2002;31(1-3):99-106.

Naidu KA, Karl RC et al. Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor. Dig Dis Sci . 2003;48(1):230-7.

Nakamura T, Takebe K et al. Effects of pancreatic digestive enzymes, sodium bicarbonate, and a proton pump inhibitor on steatorrhoea caused by pancreatic diseases. J Int Med Res . 1995;23(1):37-47.

Needle MN. Safety experience with IMC-C225, an anti-epidermal growth factor receptor antibody. Semin Oncol . 2002;29(5 Suppl 14):55-60.

Nishikawa A, Furukawa F et al. Potent chemopreventive agents against pancreatic cancer. Curr Cancer Drug Targets . 2004;4(4):373-84.

Noguchi K, Tanimura H et al. Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vitro. Anticancer Res . 1995;15(2):255-8.

Novak JF, Trnka F. Proenzyme therapy of cancer. Anticancer Res . 2005;25(2A):1157-77.

Ochi K, Harada H et al. Intraductal secretin test is as useful as duodenal secretin test in assessing exocrine pancreatic function. Dig Dis Sci . 1997;42(3):492-596.

Ohta T, Arakawa H et al. [A new strategy for the therapy of pancreatic cancer by proton pump inhibitor]. Gan To Kagaku Ryoho . 1996;23(12):1660-4.

Ohwada S, Ikeya T et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer . 2004;90(5):1003-10.

Oki Y, Younes A. Heat shock protein-based cancer vaccines. Expert Rev Vaccines . 2004;3(4):403-11.

Owen RW, Haubner R et al. Olives and olive oil in cancer prevention. Eur J Cancer Prev . 2004;13(4):319-26.

Pares A, Planas R et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol . 1998;28(4):615-21.

Perez MM, Newcomer AD et al. Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer . 1983;52(2):346-52.

Persson C, Glimelius B et al. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition . 2005;21(2):170-8.

Pezzilli R. Screening tests for pancreatic cancer: searching for the early symptoms or the population at risk. Jop 2004;5(4):240-2.

Prasad AS, Bao B et al. Antioxidant effect of zinc in humans. Free Radic Biol Med . 2004;37(8):1182-90.

Qanungo S, Das M et al. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis . 2005;26(5):958-67.

Rautalahti MT, Virtamo JR et al. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer . 1999;86(1):37-42.

Ravichandran D, Cooper A et al. Growth inhibitory effect of lithium gammalinolenate on pancreatic cancer cell lines: the influence of albumin and iron. European Journal of Cancer . 1998;34(1):188-92.

Rayes N, Hansen S et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition . 2002;18(7-8):609-15.

Recchia F, Sica G et al. Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids. Am J Clin Oncol . 1998;21(3):275-8.

Rich TA, Shepard R. COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: esophagus, stomach, and pancreas. Am J Clin Oncol . 2004;26(4):S110-S113.

Ripple GH, Gould MN et al. Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. Clin Cancer Res 2000 Feb;6(2):390-6 . 2000;6(2):390-6.

Robles-Diaz G, Duarte-Rojo A. Pancreas: a sex steroid-dependent tissue. Isr Med Assoc J . 2001;3(5):364-8.

Roomi MW, Ivanov V et al. Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2. Int J Gastrointest Cancer . 2005;35(2):97-102.

Rosenstein ED, Kushner LJ et al. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot Essent Fatty Acids . 2003;68(3):213-8.

Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: improvements in our understanding of genetics and screening. Int J Biochem Cell Biol 2004;36(8):1386-92.

Rulyak SJ, Lowenfels AB et al. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology . 2003;124(5):1292-9.

Safran H, Iannitti D et al. Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu. Cancer Invest . 2004;22(5):706-12.

Saisho H, Yamaguchi T. Diagnostic imaging for pancreatic cancer: computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas . 2004;28(3):273-8.

Saitou M, Goto M et al. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol . 2005;58(8):845-52.

Sangro B, Mazzolini G et al. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol . 2004;22(8):1389-97.

Saruc M, Standop S et al. Pancreatic enzyme extract improves survival in murine pancreatic cancer. Pancreas . 2004;28(4):401-12.

Sato T, Odagiri H et al. Chemosensitivity of human pancreatic carcinoma cells in enahnced by IkappaBalpha super-repressor. Cancer Sci . 2003;94(5):467-72.

Schibli S, Durie PR et al. Proper usage of pancreatic enzymes. Curr Opin Pulm Med . 2002;8(6):542-6.

Schima W, Fugger R et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR American Journal of Roentgenology . 2002;179(3):717-24.

Schusdziarra V, Holland A et al. Effect of naloxone on pancreatic and gastric endocrine function in response to carbohydrate and fat-rich test meals. Peptides . 1984;5(1):65-71.

Shi Y, Wu J et al. Farnesyltransferase inhibitor effects on prostate tumor micro-environment and radiation survival. Prostate . 2005;62(1):69-82.

Shiraishi K, Okita K et al. A comparison of DNA copy number changes detected by comparative genomic gybridization in malignancies of the liver, biliary tract and pancreas. Oncology . 2001;60(2):151-61.

Simon B, Printz H. Epidemiological trends in pancreatic neoplasias. Dig Dis . 2001;19(1):6-14.

Singh AP, Moniaux N et al. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res . 2004;64(2):622-30.

Singh J, Hamid R et al. Dietary fat and colon cancer: Modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res . 1997;57(2):253-8.

Singh SV. Impact of garlic organosulfides on p21(H-ras) processing. J Nutr . 2001;131(3S):1046S-8S.

Snady H, Bruckner HW et al. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer . 2000;89(2):314-27.

Sohma M, Kitagawa T et al. [Two cases of unresectable pancreatic cancer responding to combined chemotherapy with cisplatin, PSK and UFT]. Gan To Kagaku Ryoho . 1987;14(6 Pt 1):1926-9.

Sonwalkar SA, Holbrook IB et al. A prospective, comparative study of the para-aminobenzoic acid test and faecal elastase 1 in the assessment of exocrine pancreatic function. Aliment Pharmacol Ther . 2003;17(3):467-71.

Stark MJ, Burke YD et al. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett . 1995;96(1):15-21.

Stephens FO. The increased incidence of cancer of the pancreas: Is there a missing dietary factor? Can it be reversed? Aust N Z J Surg . 1999;69(5):331-5.

Stolzenberg-Solomon RZ, Pietinen P et al. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. American Journal of Epidemiology . 2001;153(7):680-7.

Suzuki K, Aiura K et al. Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology . 2004;51(57):847-53.

Takada M, Nakamura Y et al. Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas . 2002;25(1):45-8.

Takimoto CH, Glover K et al. Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiol Biomarkers Prev . 2003;12(11 Pt 1):1213-21.

Thies F, Miles EA et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids . 2001;36(11):1183-93.

Tisdale MJ. Wasting in cancer. J Nutr . 1999;129(1S Suppl):243S-6S.

Toge T, Yamaguchi Y. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. Oncol Rep . 2000;7(5):1157-61.

Tong WG, Ding XZ et al. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther . 2002;1(11):929-35.

Truninger K. [Risk groups for pancreatic and bile duct carcinomas]. Schweiz Rundsch Med Prax . 2000;89(33):1299-304.

Tsai AC, Vinik AI et al. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Am J Clin Nutr . 1987;45(3):596-601.

Tseng WW, Deganutti A et al. Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer. J Gastrointest Surg . 2002;6(6):838-43.

Tsukagoshi S, Hashimoto Y et al. Krestin (PSK). Cancer Treat Rev . 1984;11(2):131-55.

Tucker ON, Dannenberg AJ et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res . 1999;59(5):987-90.

Uden S, Schofield D et al. Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther . 1992;6(2):229-40.

Vaquero EC, Edderkaoui M et al. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem . 2004;279(33):34643-54.

Vigushin DM, Poon GK et al. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother Pharmacol . 1998;42(2):111-7.

Way TD, Kao MC et al. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem . 2004;279(6):4479-89.

Wei D, Wang L et al. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res . 2004;64(6):2030-8.

Wenger FA, Kilian M et al. Influence of antioxidative vitamins A, C and E on lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters. Prostaglandins Leukotrienes & Essential Fatty Acids . 2001;65(3):165-71.

Weydert C, Roling B et al. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Ther . 2003;2(4):361-9.

Whitehouse PA, Cooper AJ et al. Synergistic activity of gamma-linolenic acid and cytotoxic drugs against pancreatic adenocarcinoma cell lines. Pancreatology . 2003;3(5):367-73.

Wiedmann MW, Caca K. Molecularly targeted therapy for gastrointestinal cancer. Curr Cancer Drug Targets . 2005;5(3):171-93.

Wigmore SJ, Barber MD et al. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutrition & Cancer . 2000;36(2):177-84.

Wigmore SJ, Ross JA et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition . 1996;12(1 Suppl):27-30.

Wilentz RE, Chung CH et al. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer . 1998 Jan 1;82(1):96-103.

Wilson LC, Baek SJ et al. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int J Cancer . 2003;105(6):747-53.

Woutersen RA, Appel MJ et al. Modulation of pancreatic carcinogenesis by antioxidants. Food Chem Toxicol . 1999;39(9-10):981-4.

Xiong HQ, Rosenberg A et al. Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial. J Clin Oncol . 2004a;22(13):2610-6.

Xiong HQ, Rosenberg A et al. Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial. J Clin Oncol . 2004b;22(13):2610-6.

Yamaguchi K, Nakamura K et al. Intraoperative radiation enhances decline of pancreatic exocrine function after pancreatic head resection. Dig Dis Sci . 2000;45(6):1084-90.

Yamao K, Okubo K et al. Endolumenal ultrasonography in the diagnosis of pancreatic diseases. Abdom Imaging . 2003;28(4):545-55.

Yang XD, Jia XC et al. Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy. Crit Rev Oncol Hematol . 2001;38(1):17-23.

Yokoe T, Iino Y et al. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK. Anticancer Res . 1997;17(4A):2815-8.

Zemskov V, Prokopchuk O et al. Efficacy of ukrain in the treatment of pancreatic cancer. Langenbecks Arch Surg . 2002;387(2):84-9.

Zhan CD, Sindhu RK et al. Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet. J Hypertens . 2004;22(10):2025-33.

Zhang H, Morisaki T et al. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs. Clin Exp Metastasis . 2000;18(4):343-52.

Zhang H, Morisaki T et al. PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. Oncogene . 2003;22(14):2088-96.

Zullo A, Rinaldi V et al. Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study. Aliment Pharmacol Ther . 2000;14(10):1303-9.